Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul/Aug;25(3):110-113.

Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series

Alexander J Millman  1 , Boatemaa Ntiri-Reid  2 , Risha Irvin  3 , Maggie H Kaufmann  4 , Andrew Aronsohn  5 , Jeffrey S Duchin  6 , John D Scott  7 , Claudia Vellozzi  1
Affiliations

Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series

Alexander J Millman et al. Top Antivir Med. 2017 Jul/Aug.

Abstract

Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.

PubMed Disclaimer

References

    1. AASLD/IDSA. HCV guidance: recommendations for testing, managing, and treating hepatitis C. http://hcvguidelines.org/. Accessed on June 7, 2017.
    1. Barua S, Greenwald R, Grebely J, Dore GJ, Swan T, Taylor LE. Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States. Ann Intern Med. 2015;163(3):215–223. - PubMed
    1. Ward JW, Mermin JH. Simple, effective, but out of reach? Public health implications of HCV drugs. N Engl J Med. 2015;373(27):2678–2680. - PubMed
    1. Canary LA, Klevens RM, Holmberg SD. Limited access to new hepatitis C virus treatment under state Medicaid programs. Ann Intern Med. 2015;163(3):226–228. - PubMed
    1. Younossi ZM, Bacon BR, Dieterich DT, et al. Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network. J Viral Hepat. 2016;23(6):447–454. - PubMed

LinkOut - more resources